Article

Alternative strategies successful in managing IFIS

Las Vegas-Ophthalmologists can use one of several modified strategies to perform cataract surgery in patients who are taking or have taken tamsulosin (Flomax, Boehringer Ingelheim Pharmaceuticals), with good outcomes and low complication rates, when they know of the medication history in advance, David F. Chang, MD, told those attending the annual meeting of the American Academy of Ophthalmology here.

Combining different approaches also can be effective, he said. Stopping the drug is of questionable value, and pupil-stretching should be avoided, he added.

"We wanted the surgeons to be able to choose whatever strategy or combination they felt would be safest for their patients, so this was not a randomized comparison of different techniques in an attempt to see which was superior," Dr. Chang said.

Chosen strategies

Surgeons tended to use hooks and rings in patients with smaller preoperative pupil diameters (mean of 5.8 mm and 4.3 mm, respectively), which usually are indicative of more severe IFIS, Dr. Chang said.

Thirty-five percent of all of the cases involved dense nuclei, he said. Seventy-five percent of the procedures were performed using topical anesthesia. "Most [91%] were done using a phaco chop method, which indicates that these were very experienced surgeons," Dr. Chang added.

Nothing unusual was noted about the distribution of iris color, diabetes, or pseudoexfoliation in the patient population.

Results

Atropine as a single strategy was effective in only 42% (eight of 19) of the cases for which it was chosen, Dr. Chang said. In these cases, preoperative pupil diameter was very large (mean 7.2 mm) and decreased only slightly (mean 0.9 mm) by the end of the procedure. A well-dilated pupil at the start of surgery may indicate that the IFIS is less severe, he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
© 2025 MJH Life Sciences

All rights reserved.